Global /China /Healthcare /Medical Devices /688767

Hangzhou Biotest Biotech Co.,Ltd.

688767

• SSE: 688767 • Delayed

34.89CNY -2.9%

5.15 USD

As of 24 June 2026, Hangzhou Biotest Biotech Co.,Ltd. has a market cap of $774.77M USD, ranking #12243 globally and #3636 in China. It ranks #1117 in the Healthcare sector, and #220 in the Medical Devices industry.

Global Rank

12243

Country Rank

3636

Sector Rank

1117

Industry Rank

220

Key Stats

Market Cap

$774.77MUSD

5.26B CNY

Enterprise Value

$569.7MUSD

3.86B CNY

Revenue (TTM)

$66.26MUSD

449.5M CNY

EBITDA (TTM)

$8.93MUSD

60.44M CNY

Net Income (TTM)

$4.47MUSD

30.31M CNY

EBITDA Margin

13%

Profit Margin

6.7%

PE Ratio

171.7

PS Ratio

11.7

PB Ratio

2.2

EV/EBITDA

63.8

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Devices

CEO

Shujiang Wu open_in_new

Employees

622

Founded

2008

Website

biotests.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.9%	-0.6%	11%	-3.2%	-21%	-5.2%	28%	30%	-37%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688767 杭州博拓生物科技股份有限公司 Class A ISIN: CNE1000050H0 Shares Out.: Shares Outstanding: 148.247M¹ Shares Float: 148.241M² TV: TradingView: SSE: 688767 SA: Stock Analysis: SHA: 688767 YF: Yahoo Finance: 688767.SS GF: Google Finance: SHA: 688767 BA: Barron's: 688767 MS: Morningstar: XSHG: 688767	34.89 CNY	TV: TradingView: SSE: 688767 SA: Stock Analysis: SHA: 688767 YF: Yahoo Finance: 688767.SS GF: Google Finance: SHA: 688767 BA: Barron's: 688767 MS: Morningstar: XSHG: 688767

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hangzhou Biotest Biotech Co.,Ltd.

Hangzhou Biotest Biotech Co.,Ltd. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases. It also provides veterinary test kits; fluorescence immunoassay rapid test kits; and other rapid testing kits. In addition, the company is widely utilized across various medical institutions, judicial testing systems, third-party testing organizations, Centers for Disease Control and Prevention (CDC), and private clinics. The company was founded in 2008 and is based in Hangzhou, China.

Similar Companies

Industry: Medical Devices (China)

Name	Market Cap (USD) diff.	PE	Country
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.02B 203.66B CNY 4K%	26.0	China
Shanghai United Imaging Healthcare Co., Ltd. SSE: 688271	$13.6B 92.23B CNY 2K%	48.5	China
Shenzhen New Industries Biomedical Engineering Co., Ltd. SHE: 300832	$5.6B 38.02B CNY 623%	23.4	China
Intco Medical Technology Co., Ltd. SHE: 300677	$5.52B 37.43B CNY 612%	52.7	China
APT Medical Inc. SSE: 688617	$5.03B 34.14B CNY 550%	39.6	China
Andon Health Co., Ltd. SHE: 002432	$4.55B 30.86B CNY 487%	13.7	China

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 22K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 21K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 20K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 16K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 15K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 13K%	22.2	Ireland

chevron_leftBack